BridgeMD
New treatment option for Stress Disorders, Post-Traumatic
Official title Manage Emotions to Reduce Aggression (MERA)
ClinicalTrials.gov ID: NCT04793776
What this study is testing
- What it's testing
- PTSD is one of the most prevalent mental health conditions affecting Veterans who have served since 9/11. Veterans with posttraumatic stress disorder (PTSD) report difficulty controlling impulsive aggression (IA).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Male and female Veterans who deployed to combat zones since 9/11.
- Currently meets criteria for full or subthreshold PTSD, determined by the Clinician-Administered PTSD Scale for DSM-5
- Engaged in at least 3 self-reported aggressive acts (e.g., yelling, throwing objects, hitting objects/people) in the last month, measured by the...
- Impulsive aggression is his/her primary form of aggression, determined by the Impulsive Premeditated Aggression Scale
- Each Veteran must allow an independent aggression rater (live-in partner, family member, or roommate above 18 years of age)] verify the number of...
You likely can't join if
- Currently suicidal with intent of self-harm in the last week.
- Currently homicidal with plans to hurt a specific person.
- Unable to complete self-report measures.
- Meets diagnostic criteria for bipolar disorder or psychotic disorder.
- Had a psychotropic medication change within 4 weeks prior to the baseline assessment. Veterans receiving general mental health services or engaging...
See the full eligibility criteria
- Male and female Veterans who deployed to combat zones since 9/11.
- Currently meets criteria for full or subthreshold PTSD, determined by the Clinician-Administered PTSD Scale for DSM-5
- Engaged in at least 3 self-reported aggressive acts (e.g., yelling, throwing objects, hitting objects/people) in the last month, measured by the Overt Aggression Scale
- Impulsive aggression is his/her primary form of aggression, determined by the Impulsive Premeditated Aggression Scale
- Each Veteran must allow an independent aggression rater (live-in partner, family member, or roommate above 18 years of age)] verify the number of aggressive acts, using the Overt Aggression Scale.
- Agreement not to change psychotropic medications through the duration of the study.
- Currently suicidal with intent of self-harm in the last week.
- Currently homicidal with plans to hurt a specific person.
- Unable to complete self-report measures.
- Meets diagnostic criteria for bipolar disorder or psychotic disorder.
- Had a psychotropic medication change within 4 weeks prior to the baseline assessment. Veterans receiving general mental health services or engaging in usual care will be allowed to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Tampa, Florida, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tampa, Florida, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.